Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Oropharyngeal Neoplasms 12Prostatic Neoplasms 11Head and Neck Neoplasms 7Nasopharyngeal Carcinoma 6Carcinoma, Squamous Cell 6Esophageal Neoplasms 5Rectal Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Glioma 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Oligodendroglioma 2Myelodysplastic Syndromes 2Lymphatic Metastasis 2Leukemia, Myeloid, Acute 2Hypopharyngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Virus Diseases 1Vaginal Neoplasms 1

Interventions

Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2Etoposide 2liposomal doxorubicin 1dehydroftorafur 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1Zidovudine 1X-Rays 1Vincristine 1Valganciclovir 1Sirolimus 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Rituximab 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Mitozytrex 1Mitomycin 1Melphalan 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Fluorodeoxyglucose F18 1Filgrastim 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × HIV Infections × Radiotherapy, Intensity-Modulated × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡